Jeune syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:474OMIM:617088Q77.2
Who is this for?
Show terms as
16Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Jeune syndrome, also known as asphyxiating thoracic dystrophy (ATD) or Jeune asphyxiating thoracic dystrophy, is a rare inherited skeletal disorder classified among the ciliopathies. It is characterized by a narrow, bell-shaped thorax with short ribs that severely restrict lung growth and breathing, which can be life-threatening in the neonatal and infantile periods. The condition was first described by Mathis Jeune in 1955 and belongs to the group of short-rib thoracic dysplasias. The hallmark feature is the constricted thoracic cage, which leads to respiratory insufficiency of variable severity. Many affected infants experience severe respiratory distress at birth, and respiratory failure is the leading cause of mortality in the neonatal period. Additional skeletal features include short limbs (particularly shortened long bones), a characteristic 'trident' appearance of the acetabular roof on pelvic X-ray (trident acetabulum), polydactyly (extra fingers or toes) in some cases, and short stature. Beyond the skeletal system, Jeune syndrome can affect multiple organs. Renal involvement, including progressive nephronophthisis-like kidney disease and cystic renal changes, is common and may lead to chronic kidney failure in childhood or later life. Hepatic complications such as biliary dysgenesis, hepatic fibrosis, and cholestasis can also occur. Retinal dystrophy (progressive vision loss) and pancreatic abnormalities have been reported in some patients. Jeune syndrome is caused by mutations in genes involved in intraflagellar transport and cilia function, including IFT80, DYNC2H1, WDR19, IFT140, IFT172, TTC21B, WDR34, WDR60, TCTEX1D2, and others. The clinical severity is highly variable, even within families. Treatment is primarily supportive. For severe thoracic constriction, surgical thoracic expansion procedures (such as lateral thoracic expansion or vertical expandable prosthetic titanium rib implantation) may be performed to improve respiratory function. Respiratory support, including mechanical ventilation, may be necessary in the neonatal period. Renal and hepatic complications are managed as they arise, and organ transplantation may be considered in cases of end-stage organ failure. With improved surgical techniques and supportive care, survival into adulthood is increasingly possible for patients who survive the critical neonatal respiratory period.

Also known as:

Clinical phenotype terms— hover any for plain English:

NephronophthisisHP:0000090Abnormal sternum morphologyHP:0000766Postaxial foot polydactylyHP:0001830
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Jeune syndrome.

View clinical trials →

No actively recruiting trials found for Jeune syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Jeune syndrome community →

Specialists

16 foundView all specialists →
VP
Valérie Cormier-Daire, PUPH
Specialist
PI on 1 active trial
CF
Carole Faviez
Specialist
2 Jeune syndrome publications
MV
Marc Vincent
Specialist
2 Jeune syndrome publications
NG
Nicolas Garcelon
Specialist
2 Jeune syndrome publications
XC
Xiaoyi Chen
NEW BRUNSWICK, NJ
Specialist
2 Jeune syndrome publications
AB
Anita Burgun
Specialist
2 Jeune syndrome publications
LD
Lech Dudarewicz
Specialist
1 Jeune syndrome publication
VT
Vehap Topcu
Specialist
1 Jeune syndrome publication
SY
Said Furkan Yildirim
Specialist
1 Jeune syndrome publication
SS
Sophie Saunier
Specialist
2 Jeune syndrome publications
XW
Xiaomeng Wang
MOUNT PLEASANT, MI
Specialist
1 Jeune syndrome publication
EP
Elisabetta Pilotto
Specialist
1 Jeune syndrome publication
EM
Edoardo Midena
Specialist
1 Jeune syndrome publication
EL
Evelyn Longhin
Specialist
1 Jeune syndrome publication
AS
Agnieszka Stembalska
Specialist
1 Jeune syndrome publication
LF
Luisa Frizziero
Specialist
1 Jeune syndrome publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Jeune syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Jeune syndromeForum →

No community posts yet. Be the first to share your experience with Jeune syndrome.

Start the conversation →

Latest news about Jeune syndrome

No recent news articles for Jeune syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Jeune syndrome

What is Jeune syndrome?

Jeune syndrome, also known as asphyxiating thoracic dystrophy (ATD) or Jeune asphyxiating thoracic dystrophy, is a rare inherited skeletal disorder classified among the ciliopathies. It is characterized by a narrow, bell-shaped thorax with short ribs that severely restrict lung growth and breathing, which can be life-threatening in the neonatal and infantile periods. The condition was first described by Mathis Jeune in 1955 and belongs to the group of short-rib thoracic dysplasias. The hallmark feature is the constricted thoracic cage, which leads to respiratory insufficiency of variable seve

How is Jeune syndrome inherited?

Jeune syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Jeune syndrome typically begin?

Typical onset of Jeune syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Jeune syndrome?

16 specialists and care centers treating Jeune syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.